Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/11/2026

1. RKLB
2. ACVA
3. SPY
4. CRWV
5. RIOT
6. RPD
7. NVDA
8. HIMS
9. FERG
10. BBIO

Go back to Aligos Therapeutics Provides Phase 2 B-SUPREME Study Progress Updates
(NASDAQ: ALGS) Delayed: 7.28 -0.37 (4.84%)
Previous Close $7.65    52 Week High $ 
Open $7.58    52 Week Low $ 
Day High $7.82    P/E N/A 
Day Low $7.15    EPS $ 
Volume 236,590       

(NASDAQ: ALGS) Delayed: 7.28 -0.37 (4.84%)
Previous Close $7.65    52 Week High $ 
Open $7.58    52 Week Low $ 
Day High $7.82    P/E N/A 
Day Low $7.15    EPS $ 
Volume 236,590